Huang XJ - Search Results

1

The Functional and Prognostic Impact of TIGIT Expression on Bone Marrow NK Cells in Core Binding Factor-Acute Myeloid Leukemia Patients at Diagnosis.

Xie DH, Wang J, Sun K, Shi ZY, Wang YZ, Chang Y, Yuan XY, Liu YR, Jiang H, Jiang Q, Huang XJ, Qin YZ. Xie DH, et al. Among authors: huang xj. Biomedicines. 2024 Sep 27;12(10):2207. doi: 10.3390/biomedicines12102207. Biomedicines. 2024. PMID: 39457520 Free PMC article.

2

[Relationship between cytopenia and cytogenetic response in imatinib mesylate treated Ph-positive chronic myeloid leukemia in chronic phase patients].

Jiang Q, Chen S, Jiang B, Jiang H, Lu Y, Huang X, Lu D. Jiang Q, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2003 Apr 18;35(2):136-40. Beijing Da Xue Xue Bao Yi Xue Ban. 2003. PMID: 12920827 Free article. Chinese.

3

Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children.

Liu D, Huang X, Liu K, Xu L, Chen H, Han W, Chen Y, Zhang X, Jiang Q. Liu D, et al. Biol Blood Marrow Transplant. 2008 Apr;14(4):469-77. doi: 10.1016/j.bbmt.2008.02.007. Biol Blood Marrow Transplant. 2008. PMID: 18342790 Free article.

4

Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up.

Qin Y, Jiang B, Jiang Q, Jiang H, Li J, Zhang Y, Zhu H, Li L, Chen S, Liu Y, Huang X. Qin Y, et al. Ann Hematol. 2009 Jan;88(1):37-41. doi: 10.1007/s00277-008-0548-y. Epub 2008 Jul 24. Ann Hematol. 2009. PMID: 18651143

5

Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.

Qin Y, Zhu H, Jiang B, Li J, Lu X, Li L, Ruan G, Liu Y, Chen S, Huang X. Qin Y, et al. Leuk Res. 2009 Mar;33(3):384-90. doi: 10.1016/j.leukres.2008.08.026. Epub 2008 Oct 23. Leuk Res. 2009. PMID: 18950857

6

Characteristics of BCR-ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients.

Qin Y, Chen S, Jiang B, Jiang Q, Jiang H, Li J, Li L, Lai Y, Liu Y, Huang X. Qin Y, et al. Ann Hematol. 2011 Jan;90(1):47-52. doi: 10.1007/s00277-010-1039-5. Epub 2010 Aug 10. Ann Hematol. 2011. PMID: 20697894

7

Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.

Niu J, Li H, Zhang Y, Li J, Xie M, Li L, Qin X, Qin Y, Guo X, Jiang Q, Liu Y, Chen S, Huang X, Han W, Ruan G. Niu J, et al. Leuk Res. 2011 Jun;35(6):771-6. doi: 10.1016/j.leukres.2010.11.023. Epub 2010 Dec 18. Leuk Res. 2011. PMID: 21168207

8

CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation.

Zhu HH, Liu YR, Jiang H, Lu J, Qin YZ, Jiang Q, Bao L, Ruan GR, Jiang B, Huang X. Zhu HH, et al. Leuk Res. 2013 Jun;37(6):624-30. doi: 10.1016/j.leukres.2013.02.007. Epub 2013 Mar 6. Leuk Res. 2013. PMID: 23473998

9

CXCR4 is a good survival prognostic indicator in multiple myeloma patients.

Bao L, Lai Y, Liu Y, Qin Y, Zhao X, Lu X, Jiang Q, Lu J, Huang X. Bao L, et al. Leuk Res. 2013 Sep;37(9):1083-8. doi: 10.1016/j.leukres.2013.06.002. Epub 2013 Jul 11. Leuk Res. 2013. PMID: 23849988

10

Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-trans retinoic acid and arsenic compound-based combined therapies.

Lu J, Huang X, Bao L, Jiang H, Zhu H, Jiang B. Lu J, et al. Oncol Lett. 2014 Jan;7(1):177-182. doi: 10.3892/ol.2013.1643. Epub 2013 Oct 25. Oncol Lett. 2014. PMID: 24348844 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,764 results

Search Page

Filters